Neuland Laboratories
Logotype for Neuland Laboratories Limited

Neuland Laboratories (524558) investor relations material

Neuland Laboratories Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Neuland Laboratories Limited
Q3 25/26 earnings summary9 Feb, 2026

Executive summary

  • Q3 FY26 total income reached INR 447.8 crore, up 11.4% year-over-year, with commercial CMS projects contributing over 50% of revenue; EBITDA margin was subdued due to product mix and higher operating expenses.

  • Business momentum remains strong, with investments in NCE drug substance manufacturing and a ramp-up phase for new CMS molecules and capacity expansions.

  • Unaudited financial results for the quarter and nine months ended December 31, 2025, were approved by the Board on February 9, 2026, covering both standalone and consolidated financials.

  • Results include wholly owned subsidiaries in the USA and Japan, with consolidated Q3 FY26 net profit at ₹4,057.19 lakhs and EPS at ₹31.62.

  • The business is experiencing a ramp-up phase, with new CMS molecules commercialized and capacity expansions underway.

Financial highlights

  • Q3 FY26 total income: INR 447.8 crore, up 11.4% YoY; 9MFY26 total income: INR 1,264.4 crore, up 8.9% YoY.

  • Consolidated Q3 FY26 revenue was ₹43,970.93 lakhs, up from ₹39,803.18 lakhs in Q3 FY25; net profit was ₹4,057.19 lakhs.

  • Gross margin for Q3 FY26 was 52.1%, down from 53.2% in Q3 FY25; nine-month gross margin maintained at 56% versus 55% last year.

  • EBITDA for Q3 FY26 was INR 85 crore (19% margin), with adjusted EBITDA at INR 95 crore (21% margin) excluding one-time labor costs.

  • Net debt at Q3 FY26 end: INR -202.6 crore, improved from INR -185.1 crore at Q3 FY25 end.

Outlook and guidance

  • Management expects FY26 to be a growth year, with optimism for the future based on the current commercial base and ramp-up of new products.

  • Continued investments in R&D and capacity to capture growth opportunities in high-value segments; peptide facility commissioning in July, with commercial manufacturing targeted for FY27.

  • Board approved R&D move to a new leased facility, with INR 254 crore capex in 9MFY26.

  • Management emphasizes a medium- to long-term view due to the inherent lumpiness and long gestation periods in the CDMO and specialty businesses.

  • New Indian labour codes effective November 21, 2025, have no material incremental impact.

Q3 geographic revenue divergence drivers?
Clarify unreviewed subsidiary financials.
Explain the significant Q3 inventory changes.
How will new R&D and peptide CapEx drive growth?
Plan to reduce high inventory and working capital days?
What product mix changes impact gross margin?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Neuland Laboratories earnings date

Logotype for Neuland Laboratories Limited
Q4 25/2614 May, 2026
Neuland Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Neuland Laboratories earnings date

Logotype for Neuland Laboratories Limited
Q4 25/2614 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage